Thomas Chester

US Patent:

20220262527, Aug 18, 2022

Filed:

Mar 8, 2022

Appl. No.:

17/653906

Inventors:

- New York NY, US
Dana Kupersmith - New York NY, US
Karl Kieburtz - Middleburg VA, US
Thomas Michael Chester - Shalimar FL, US

International Classification:

G16H 70/40
G16H 50/20
G16H 20/10
G16H 50/70
G06K 9/62
G06F 16/903
G16H 10/60
G06F 40/205
G06F 40/20

Abstract:

A system for identifying secondary effects of medications. The system may include one or more processors and a storage medium. The storage medium may stores instructions that configure the processors to perform operations. As configured, the processors may retrieve records associated with medications from servers. The processors may also extract machine readable content from records and identify portions that are associated with secondary effects of medications. Further, the processors may aggregate identified portions in a database, determine a level of evidence for records based on sources, associate records with metadata indicating the level of evidence; and generate index files mapping the markup language files, the metadata tags, and the medications. Moreover, the processor may receive search queries from a client, identify a subset of the records associated with medications in the query using index files, and transmit the identified subset ranked according to the level of evidence.

US Patent:

20190304604, Oct 3, 2019

Filed:

Apr 2, 2019

Appl. No.:

16/372902

Inventors:

- New York NY, US
Dana Kupersmith - New York NY, US
Karl Kieburtz - Middleburg VA, US
Thomas Michael Chester - Shalimar FL, US

International Classification:

G16H 50/20
G16H 20/10
G16H 50/70
G16H 10/60
G06K 9/62
G06F 16/903
G06F 17/27

Abstract:

A system for identifying secondary effects of medications. The system may include one or more processors and a storage medium. The storage medium may stores instructions that configure the processors to perform operations. As configured, the processors may retrieve records associated with medications from servers. The processors may also extract machine readable content from records and identify portions that are associated with secondary effects of medications. Further, the processors may aggregate identified portions in a database, determine a level of evidence for records based on sources, associate records with metadata indicating the level of evidence; and generate index files mapping the markup language files, the metadata tags, and the medications. Moreover, the processor may receive search queries from a client, identify a subset of the records associated with medications in the query using index files, and transmit the identified subset ranked according to the level of evidence.